• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 309-323 of 502 results

3004 Exhibit: Correspondence Requests for Authorization

Document IPR2017-01622, No. 3004-202 Exhibit - Correspondence Requests for Authorization (P.T.A.B. Feb. 28, 2018)

cite Cite Document

1108 Exhibit: Gilead, Form 10K, 2013

Document IPR2017-01622, No. 1108-99 Exhibit - Gilead, Form 10K, 2013 (P.T.A.B. Jun. 21, 2017)

cite Cite Document

1045 Exhibit: Electronic Medicines Compendium, Ventavis, httpwwwmedicinesorgu...

Document IPR2017-01622, No. 1045-40 Exhibit - Electronic Medicines Compendium, Ventavis, httpwwwmedicinesorgukemchistory13743version1 noting a change to section 42 Posology and Method of A...

cite Cite Document

1142 Exhibit: UTC, Q2 2010 United Therapeutics Earnings Conference Call, 72820...

Document IPR2017-01622, No. 1142-131 Exhibit - UTC, Q2 2010 United Therapeutics Earnings Conference Call, 7282010 (P.T.A.B. Jun. 21, 2017)

cite Cite Document

1092 Exhibit: FDA Drug Details Website, Orenitram, httpswwwaccessdatafdagovsc...

Document IPR2017-01622, No. 1092-83 Exhibit - FDA Drug Details Website, Orenitram, httpswwwaccessdatafdagovscriptscderdafindexcfmeventBasicSearchprocess accessed 5172017 (P.T.A.B. Jun. 21...

cite Cite Document

1013 Exhibit: Declaration of Scott Bennett, PhD Part 22

Document IPR2017-01622, No. 1013-161 Exhibit - Declaration of Scott Bennett, PhD Part 22 (P.T.A.B. Jun. 21, 2017)

cite Cite Document

1135 Exhibit: RBC Capital Markets, Untied Therapeutics Corp, 6132011

Document IPR2017-01622, No. 1135-125 Exhibit - RBC Capital Markets, Untied Therapeutics Corp, 6132011 (P.T.A.B. Jun. 21, 2017)

cite Cite Document

1046 Exhibit: Voswinckel, R, et al, Inhaled treprostinil is a potent pulmonary vasodi...

Document IPR2017-01622, No. 1046-154 Exhibit - Voswinckel, R, et al, Inhaled treprostinil is a potent pulmonary vasodilator in severe pulmonary hypertension, 25 European Heart Journal 22, at 218 2004 ...

cite Cite Document

1087 Exhibit: FDA Drug Details Website, Adcirca, httpswwwaccessdatafdagovscrip...

Document IPR2017-01622, No. 1087-79 Exhibit - FDA Drug Details Website, Adcirca, httpswwwaccessdatafdagovscriptscderdafindexcfmeventBasicSearchprocess accessed 5172017 (P.T.A.B. Jun. 21, 2...

cite Cite Document

1096 Exhibit: FDA Drug Details Website, Tyvaso, httpswwwaccessdatafdagovscript...

Document IPR2017-01622, No. 1096-87 Exhibit - FDA Drug Details Website, Tyvaso, httpswwwaccessdatafdagovscriptscderdafindexcfmeventBasicSearchprocess accessed 5172017 (P.T.A.B. Jun. 21, 20...

cite Cite Document

1031 Exhibit: US Patent No 5,544,646

Document IPR2017-01622, No. 1031-26 Exhibit - US Patent No 5,544,646 (P.T.A.B. Jun. 21, 2017)

cite Cite Document

1133 Exhibit: Pfizer, Annual Report, 2015

Document IPR2017-01622, No. 1133-123 Exhibit - Pfizer, Annual Report, 2015 (P.T.A.B. Jun. 21, 2017)

cite Cite Document

1032 Exhibit: Edwards DA et al, Recent Advances in Pulmonary Drug Delivery Usin...

Document IPR2017-01622, No. 1032-27 Exhibit - Edwards DA et al, Recent Advances in Pulmonary Drug Delivery Using Large Porous Inhaled Particles, Journal of Applied Physiology, 852 379 385 1998 (P...

cite Cite Document

1075 Exhibit: Adempas, FDA Label, 102016

Document IPR2017-01622, No. 1075-67 Exhibit - Adempas, FDA Label, 102016 (P.T.A.B. Jun. 21, 2017)

cite Cite Document

1095 Exhibit: FDA Drug Details Website, Tracleer, httpswwwaccessdatafdagovscrip...

Document IPR2017-01622, No. 1095-86 Exhibit - FDA Drug Details Website, Tracleer, httpswwwaccessdatafdagovscriptscderdafindexcfmeventBasicSearchprocess accessed 5172017 (P.T.A.B. Jun. 21, 2...

cite Cite Document
<< 1 2 3 4 5 ... 21 22 23 24 25 ... >>